Abstract Submission

ESPACOMP 2022: call for late-breaking abstracts is open

Dear Colleagues,

Following several inquiries by members, ESPACOMP is opening this year a Call for Late-breaking Abstracts. We have already received over 90 abstracts and we are currently communicating results of abstract reviewing to authors. The scientific programme will be available soon on the ESPACOMP website and we are looking forward to a hybrid event showcasing a diverse range of oral and poster presentations.

We invite you to submit abstracts presenting new information that was not fully available by the regular abstract submission deadline, July 15th. As for the regular call for abstracts, we welcome submissions on all aspects of medication adherence research (e.g. intervention research, observational studies, implementation science, measurement studies, policy evaluation).

The deadline for abstract submission is 11:59pm (CET) August 31, 2022. Submitted abstracts will be scored by reviewers, and decisions on their acceptance as poster presentations will be communicated by mid-September.

The 26th ESPACOMP Conference will be held in a hybrid format from November 17th to 19th 2022 in Berlin, Germany. It will have a special focus on Adherence and Patient Safety. Information about online and in person participation will be made available soon on the society website and social media: on LinkedIn (in “Groups” search for “ESPACOMP’) or on Twitter (@SocMedAdherence).

Accepted and presented abstracts will be published in International Journal of Clinical Pharmacy.

Abstract Format:

  • Abstracts must be structured, with section headings for Aim, Methods, Results, Discussion, and Conclusion

  • Abstracts must be limited to 250 words, including the title

  • Abstracts must adopt the ESPACOMP-endorsed ABC Taxonomy, available here

  • Authors must present in the abstract, in as much detail as space permits, information on the 4 minimum reporting criteria outlined in the ESPACOMP EMERGE reporting guidelines. These are available here

Additional information about the meeting program will be posted at www.espacomp.eu when it is available.

Specific questions about the ESPACOMP conference may be directed to info@espacomp.eu.

    Authors must present in the abstract, in as much detail as space permits, information on the 4 minimum reporting criteria report according to the ESPACOMP EMERGE reporting guidelines

    words. Please limit to 235 words or less With Space.

    Due to copyright restrictions, the abstracts accepted for presentation at ESPACOMP that have been previously presented at other conferences, or already published, can not be accepted for publication in the International Journal of Clinical Pharmacy. Has this work been previously presented or published?